Wednesday, July 8, 2026

Drug profile · INN

indium in-111 pentetreotide kit

indium in-111 pentetreotide kit (INDIUM IN-111 PENTETREOTIDE KIT) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — indium in-111 pentetreotide kit
US status
approved
Class
Route
INJECTION
Patents
0
Programs
1
Data quality
0.84

Quick answer

indium in-111 pentetreotide kit (INDIUM IN-111 PENTETREOTIDE KIT) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN indium in-111 pentetreotide kit
Brand INDIUM IN-111 PENTETREOTIDE KIT
Mechanism Diagnostic agent
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. OCT Unknown · Cardiff Oncology · AMD

Frequently asked questions

What is indium in-111 pentetreotide kit?

indium in-111 pentetreotide kit (INDIUM IN-111 PENTETREOTIDE KIT) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for indium in-111 pentetreotide kit?

INDIUM IN-111 PENTETREOTIDE KIT is a marketed brand name for indium in-111 pentetreotide kit. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of indium in-111 pentetreotide kit?

indium in-111 pentetreotide kit has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.